Latest Orna Therapeutics News & Updates
See the latest news and media coverage for Orna Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of engineered circular RNA therapeutics
ornatx.com- Headquarters
- Watertown, United States
- Founded year
- 2019
- Company type
- Private company
- Number of employees
- 150–200
Latest news about Orna Therapeutics
Company announcements
-
Lilly agrees to acquire Orna Therapeutics
The deal, worth up to $2.4 billion, advances Orna's in vivo CAR-T therapies for autoimmune diseases using circular RNA.
-
Orna Therapeutics shares new data at ASH 2025
They presented posters and oral sessions on oRNA® technology for in vivo pan-CAR therapies targeting multiple myeloma and autoimmune diseases.
-
Orna Therapeutics presents preclinical data on in vivo CAR programs
Data supports anti-CD19 ORN-252 for autoimmune diseases and anti-BCMA for oncology, shown at ASH 2025. Plans CTA submission by end 2025.
-
Orna Therapeutics announces presentations at ASH 2025
Presentations highlight in vivo CAR programs for autoimmune diseases and anti-BCMA platform, including NHP study data and CTA submission plans.
Media coverage
-
Lilly strikes again, buying CAR-T firm Orna for $2.4bn
Eli Lilly has signed its second pipeline-building deal in two days, reaching an agreement to buy in vivo CAR-T developer Orna Therapeutics for up to...
-
Lilly bets on next-generation cell therapy with $2.4 billion deal for Orna
Feb 9 (Reuters) - Eli Lilly will buy Orna Therapeutics for up to $2.4 billion in cash, gaining access to a technology that allows patients...
-
Eli Lilly Acquires Orna Therapeutics in $2.4 Billion Genetic Medicine Push
Orna’s lead program is a clinical trial-ready in-vivo CAR T therapy designed to treat B cell-driven autoimmune diseases...
-
Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion
Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash. Eli Lilly on Monday said...
Track Orna Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group
FAKRO